Eye Drop Recall Could Impact Arkansas Consumers

Millions of eye drops recalled nationwide over contamination concerns - KBSI FOX23 News Cape Girardeau News

(KBSI) — Federal health officials are urging people to check their medicine cabinets after millions of eye drop bottles were pulled from shelves across the country. According to the U.S. Food and Drug Administration, a California-based manufacturer has recalled more than 3 million bottles of eye drops sold at major retailers such as Walgreens, CVS and Kroger over concerns about how the products were made. Officials say the issue involves sterili…

Recall: 3.1 million bottles of eye drops sold at Walgreens, CVS, Harris Teeter and Publix

More than 3.1 million bottles of eye drops sold at major retailers like Walgreens and CVS are being recalled by K.C. Pharmaceuticals, Inc., due to sterility concerns.

Eye drop recall could impact Arkansas consumers

Arkansas consumers are being urged to check their medicine cabinets after more than 3 million bottles of eye drops were recalled nationwide. The U.S. Food and Drug Administration says K.C. Pharmaceuticals, Inc. voluntarily recalled about 3.1 million bottles due to a lack of assurance of sterility, meaning the products may not have been manufactured in a way that prevents contamination from bacteria or other microbes. The recalled products were d…

FDA Recall Covers Over 3.1 Million Eye Drop Bottles Over Sterility Concerns

More than 3.1 million bottles of eye drops sold at major retailers have been recalled due to sterility concerns, according to a notice from the Food and Drug Administration. The products were distributed under multiple brand names and sold through national pharmacy chains and retail outlets. Recall Initiated By Manufacturer And Classified As Class II The recall was issued by K.C. Pharmaceuticals and announced in a March 3 alert. The affected pro…

FDA: Nationwide recall issued for eye drops over sterility concerns - WRNJ Radio

The U.S. Food and Drug Administration announced a nationwide recall of multiple over-the-counter eye drop products due to a lack of assurance of sterility. The recall, initiated March 3 by K.C. Pharmaceuticals Inc. of Pomona, California, affects products distributed nationwide in the United States. The recall was classified as Class II on March 31. According to the FDA, the recall involves more than 3 million bottles of eye drops sold under a va…